Your browser doesn't support javascript.
loading
Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes.
Chen, Zhishan; Guo, Xingyi; Tao, Ran; Huyghe, Jeroen R; Law, Philip J; Fernandez-Rozadilla, Ceres; Ping, Jie; Jia, Guochong; Long, Jirong; Li, Chao; Shen, Quanhu; Xie, Yuhan; Timofeeva, Maria N; Thomas, Minta; Schmit, Stephanie L; Díez-Obrero, Virginia; Devall, Matthew; Moratalla-Navarro, Ferran; Fernandez-Tajes, Juan; Palles, Claire; Sherwood, Kitty; Briggs, Sarah E W; Svinti, Victoria; Donnelly, Kevin; Farrington, Susan M; Blackmur, James; Vaughan-Shaw, Peter G; Shu, Xiao-Ou; Lu, Yingchang; Broderick, Peter; Studd, James; Harrison, Tabitha A; Conti, David V; Schumacher, Fredrick R; Melas, Marilena; Rennert, Gad; Obón-Santacana, Mireia; Martín-Sánchez, Vicente; Oh, Jae Hwan; Kim, Jeongseon; Jee, Sun Ha; Jung, Keum Ji; Kweon, Sun-Seog; Shin, Min-Ho; Shin, Aesun; Ahn, Yoon-Ok; Kim, Dong-Hyun; Oze, Isao; Wen, Wanqing; Matsuo, Keitaro.
Afiliação
  • Chen Z; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Guo X; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Tao R; Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Huyghe JR; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Law PJ; Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, 37232, TN, USA.
  • Fernandez-Rozadilla C; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Ping J; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
  • Jia G; Edinburgh Cancer Research Centre, Institute of Genomics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Long J; Genomic Medicine Group, Instituto de Investigacion Sanitaria de Santiago, Santiago de Compostela, Spain.
  • Li C; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Shen Q; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Xie Y; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Timofeeva MN; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Thomas M; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Schmit SL; Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA.
  • Díez-Obrero V; Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Devall M; Danish Institute for Advanced Study, Department of Public Health, University of Southern Denmark, Odense, Denmark.
  • Moratalla-Navarro F; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Fernandez-Tajes J; Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Palles C; Population and Cancer Prevention Program, Case Comprehensive Cancer Center, Cleveland, OH, USA.
  • Sherwood K; Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute, Barcelona, Spain.
  • Briggs SEW; Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.
  • Svinti V; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.
  • Donnelly K; Oncology Data Analytics Program, Catalan Institute of Oncology, Barcelona, Spain.
  • Farrington SM; Center for Public Health Genomics, Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA.
  • Blackmur J; Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute, Barcelona, Spain.
  • Vaughan-Shaw PG; Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.
  • Shu XO; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.
  • Lu Y; Oncology Data Analytics Program, Catalan Institute of Oncology, Barcelona, Spain.
  • Broderick P; Edinburgh Cancer Research Centre, Institute of Genomics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Studd J; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Harrison TA; Edinburgh Cancer Research Centre, Institute of Genomics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Conti DV; Department of Public Health, Richard Doll Building, University of Oxford, Oxford, UK.
  • Schumacher FR; Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Melas M; Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Rennert G; Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Obón-Santacana M; Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Martín-Sánchez V; Colon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Oh JH; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Kim J; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Jee SH; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
  • Jung KJ; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
  • Kweon SS; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Shin MH; Department of Preventive Medicine, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Shin A; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
  • Ahn YO; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.
  • Kim DH; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
  • Oze I; Clalit National Cancer Control Center, Haifa, Israel.
  • Wen W; Department of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center, Haifa, Israel.
  • Matsuo K; Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Nat Commun ; 15(1): 3557, 2024 Apr 26.
Article em En | MEDLINE | ID: mdl-38670944
ABSTRACT
Genome-wide association studies (GWAS) have identified more than 200 common genetic variants independently associated with colorectal cancer (CRC) risk, but the causal variants and target genes are mostly unknown. We sought to fine-map all known CRC risk loci using GWAS data from 100,204 cases and 154,587 controls of East Asian and European ancestry. Our stepwise conditional analyses revealed 238 independent association signals of CRC risk, each with a set of credible causal variants (CCVs), of which 28 signals had a single CCV. Our cis-eQTL/mQTL and colocalization analyses using colorectal tissue-specific transcriptome and methylome data separately from 1299 and 321 individuals, along with functional genomic investigation, uncovered 136 putative CRC susceptibility genes, including 56 genes not previously reported. Analyses of single-cell RNA-seq data from colorectal tissues revealed 17 putative CRC susceptibility genes with distinct expression patterns in specific cell types. Analyses of whole exome sequencing data provided additional support for several target genes identified in this study as CRC susceptibility genes. Enrichment analyses of the 136 genes uncover pathways not previously linked to CRC risk. Our study substantially expanded association signals for CRC and provided additional insight into the biological mechanisms underlying CRC development.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Predisposição Genética para Doença / Polimorfismo de Nucleotídeo Único / Locos de Características Quantitativas / Povo Asiático / População Branca / Estudo de Associação Genômica Ampla Limite: Female / Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Predisposição Genética para Doença / Polimorfismo de Nucleotídeo Único / Locos de Características Quantitativas / Povo Asiático / População Branca / Estudo de Associação Genômica Ampla Limite: Female / Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos
...